RBA Wealth Management’s Pfizer PFE Stock Holding History

RBA Wealth Management’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-39,770	Closed	-$1.62M	–	93
2023 Q1	$1.62M	Buy	39,770 +11,894	+43%	+$514K	0.81%	45
2022 Q4	$1.43M	Buy	27,876 +16,579	+147%	+$795K	0.75%	47
2022 Q3	$494K	Buy	11,297 +4,719	+72%	+$229K	0.28%	59
2022 Q2	$345K	Buy	6,578 +82	+1%	+$4.18K	0.19%	68
2022 Q1	$336K	Buy	6,496 +1	+0%	+$52	0.16%	80
2021 Q4	$384K	Buy	+6,495	New	+$322K	0.18%	79
2021 Q1	–	Sell	-6,560	Closed	-$241K	–	246
2020 Q4	$241K	Sell	6,560 -657	-9%	-$24.1K	0.15%	93
2020 Q3	$251K	Sell	7,217 -1,896	-21%	-$66.5K	0.17%	91
2020 Q2	$283K	Sell	9,113 -1,146	-11%	-$38.9K	0.21%	85
2020 Q1	$318K	Sell	10,259 -134	-1%	-$4.57K	0.28%	82
2019 Q4	$384K	Sell	10,393 -1,410	-12%	-$50.2K	0.26%	77
2019 Q3	$402K	Sell	11,803 -7,599	-39%	-$276K	0.31%	66
2019 Q2	$797K	Sell	19,402 -154	-0.8%	-$6.12K	0.62%	49
2019 Q1	$793K	Buy	+19,556	New	+$783K	0.62%	49

Other funds holding PFE

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

RBA Wealth Management's PFE Position: Q2 2023 in Review

RBA Wealth Management sold out of Pfizer (PFE) in Q2 2023, closing a stake of 39,770 shares — an estimated $1.62M sold.

RBA Wealth Management first reported a position in PFE in Q1 2019 and held it in 14 quarters. The position peaked at $1.62M in Q1 2023. 3,042 funds tracked by Wall St. Rank hold PFE as of Q2 2023.

RBA Wealth Management reported no remaining Pfizer position as of Q2 2023 after selling out during the quarter.
RBA Wealth Management sold 39,770 Pfizer shares in Q2 2023, an estimated $1.62M.
RBA Wealth Management first reported a position in Pfizer in Q1 2019 and held it in 14 quarters.
RBA Wealth Management's Pfizer position peaked at $1.62M in Q1 2023.
3,042 funds tracked by Wall St. Rank held Pfizer as of Q2 2023.

Based on RBA Wealth Management's 13F filing for Q2 2023, filed 21 Jul 2023.